Role of potassium-competitive acid blockers in eradication of Helicobacter pylori infection

被引:0
|
作者
Kim, Tae Ho [1 ,2 ]
机构
[1] Catholic Univ Korea, Bucheon St, Bucheon, South Korea
[2] Bucheon St, 327 Sosa-ro, Bucheon, South Korea
来源
KOREAN JOURNAL OF INTERNAL MEDICINE | 2023年 / 38卷 / 04期
关键词
TRIPLE THERAPY; VONOPRAZAN; 1ST-LINE;
D O I
10.3904/kjim.2023.250
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:451 / 453
页数:3
相关论文
共 50 条
  • [1] Eradication of Helicobacter pylori by a potassium-competitive acid blocker alone?
    Waldum, Helge
    Fossmark, Reidar
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2025, 60 (01) : 10 - 12
  • [2] Helicobacter pylori Eradication with Proton Pump Inhibitors or Potassium-Competitive Acid Blockers: The Effect of Clarithromycin Resistance
    Matsumoto, Hiroshi
    Shiotani, Akiko
    Katsumata, Ryo
    Fujita, Minoru
    Nakato, Rui
    Murao, Takahisa
    Ishii, Manabu
    Kamada, Tomoari
    Haruma, Ken
    Graham, David Y.
    DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (11) : 3215 - 3220
  • [3] Helicobacter pylori Eradication with Proton Pump Inhibitors or Potassium-Competitive Acid Blockers: The Effect of Clarithromycin Resistance
    Hiroshi Matsumoto
    Akiko Shiotani
    Ryo Katsumata
    Minoru Fujita
    Rui Nakato
    Takahisa Murao
    Manabu Ishii
    Tomoari Kamada
    Ken Haruma
    David Y. Graham
    Digestive Diseases and Sciences, 2016, 61 : 3215 - 3220
  • [4] Potassium-competitive acid blockers: rethinking acid suppression for gastroesophageal reflux disease and Helicobacter pylori
    Antequera, Carol M.
    Orleck, Kimberly
    Jacob, Rinu
    Kenneally, Amy
    Wright, Wendy L.
    POSTGRADUATE MEDICINE, 2024, 136 (02) : 131 - 140
  • [5] The cost effectiveness of vonoprazan, a novel potassium-competitive acid blocker, as a component of Helicobacter pylori eradication therapy
    Hosokawa, Takanori
    Kaminishi, Michio
    Nouchi, Toshihiko
    Takeda, Yuichi
    Kojima, Shigeru
    Ono, Keichi
    Uraushihara, Koji
    Yamadi, Osamu
    Suzuki, Shoko
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 62 - 62
  • [6] Is a Potassium-Competitive Acid Blocker Truly Superior to Proton Pump Inhibitors in Terms of Helicobacter pylori Eradication?
    Sue, Soichiro
    Maeda, Shin
    GUT AND LIVER, 2021, 15 (06) : 799 - 810
  • [7] Helicobacter pylori Eradication Therapy With a Potassium-Competitive Acid Blocker, Metronidazole, and Sitafloxacin in Patients With Penicillin Allergy
    Tanaka, Akifumi
    Tokunaga, Kengo
    Takahashi, Shin'ichi
    Mori, Hideaki
    Hisamatsu, Tadakazu
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S680 - S680
  • [8] Efficacy and tolerability of a triple therapy containing a potassium-competitive acid blocker for Helicobacter pylori infection
    Suzuki, Sho
    Gotoda, Takuji
    Kusano, Chika
    Iwatsuka, Kunio
    Moriyama, Mitsuhiko
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 68 - 68
  • [9] Safety of first-line triple therapy with a potassium-competitive acid blocker for Helicobacter pylori eradication in children
    Chika Kusano
    Takuji Gotoda
    Sho Suzuki
    Hisatomo Ikehara
    Mitsuhiko Moriyama
    Journal of Gastroenterology, 2018, 53 : 718 - 724
  • [10] Safety of first-line triple therapy with a potassium-competitive acid blocker for Helicobacter pylori eradication in children
    Kusano, Chika
    Gotoda, Takuji
    Suzuki, Sho
    Ikehara, Hisatomo
    Moriyama, Mitsuhiko
    JOURNAL OF GASTROENTEROLOGY, 2018, 53 (06) : 718 - 724